Tumor-Targeting Antibody–Anticalin Fusion Proteins for in Vivo Pretargeting Applications-Reference-Cited by-同舟云学术

Tumor-Targeting Antibody–Anticalin Fusion Proteins for in Vivo Pretargeting Applications

Published:2013-02-06 Issue:2 Volume:24 Page:234-241
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Steiner Martina¹,Gutbrodt Katrin¹,Krall Nikolaus¹,Neri Dario¹

Affiliation:

1. Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich), Wolfgang-Pauli-Strasse 10, CH-8093 Zürich, Switzerland

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc300567a

Reference47 articles.

1. Recent trends in antibody-based oncologic imaging

2. Potent antibody therapeutics by design

3. Selective targeting of tumoral vasculature: Comparison of different formats of an antibody (L19) to the ED-B domain of fibronectin

4. Arming antibodies: prospects and challenges for immunoconjugates

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficient Combinatorial Adaptor-Mediated Targeting of Acute Myeloid Leukemia with CAR T-Cells;2024-07-15

2. Anticalin® proteins: from bench to bedside;Expert Opinion on Biological Therapy;2020-11-01

3. Bispecific applications of non-immunoglobulin scaffold binders;Methods;2019-02

4. Mabfilin and Fabfilin - New antibody-scaffold fusion formats for multispecific targeting concepts;Protein Expression and Purification;2018-09

5. RPtag as an Orally Bioavailable, Hyperstable Epitope Tag and Generalizable Protein Binding Scaffold;Biochemistry;2018-05-03